Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Corticosteroid injections helped eyebrow hair regrow in men with alopecia areata.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.